Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix

T Satoh, Y Takei, I Treilleux… - International Journal of …, 2014 - ijgc.bmj.com
Small cell carcinoma of the cervix (SCCC) is a rare histological entity of uterine cervical
cancer. Compared with other common histological types, squamous cell carcinoma or …

[HTML][HTML] Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria

H Katayama, Y Kurokawa, K Nakamura, H Ito… - Surgery today, 2016 - Springer
Purpose Prior to publication of the Clavien-Dindo classification in 2004, there were no
grading definitions for surgical complications in either clinical practice or surgical trials. This …

[HTML][HTML] Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an …

E Bentivegna, R Fruscio, S Roussin, L Ceppi, T Satoh… - Fertility and sterility, 2015 - Elsevier
Objective To determine the long-term outcomes of patients with an isolated ovarian
recurrence after fertility sparing surgery (FSS) for epithelial ovarian cancer (EOC) and to …

Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505

R Kitagawa, N Katsumata, T Shibata… - Journal of clinical …, 2015 - ascopubs.org
Purpose In metastatic or recurrent cervical cancer, cisplatin-based chemotherapy is
standard. The JCOG0505 randomized phase III trial evaluated the clinical benefits of …

[HTML][HTML] Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III …

T Onda, T Satoh, T Saito, T Kasamatsu… - European journal of …, 2016 - Elsevier
Background We conducted a phase III, non-inferiority trial comparing upfront primary
debulking surgery (PDS) and interval debulking surgery (IDS) following neoadjuvant …

[PDF][PDF] Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection

T Satoh, M Hatae, Y Watanabe, N Yaegashi… - J Clin …, 2010 - researchgate.net
Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for
Patient Selection Page 1 Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian …

[HTML][HTML] Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III …

T Onda, T Satoh, G Ogawa, T Saito… - European Journal of …, 2020 - Elsevier
Background Regarding the comparison between primary debulking surgery (PDS) and
neoadjuvant chemotherapy (NACT) for stage III/IV ovarian, tubal and peritoneal cancers …

Human papillomavirus infections among Japanese women: age‐related prevalence and type‐specific risk for cervical cancer

M Onuki, K Matsumoto, T Satoh, A Oki, S Okada… - Cancer …, 2009 - Wiley Online Library
To obtain baseline data for human papillomavirus (HPV) screening and vaccination in
Japan, we analyzed HPV DNA data from 2282 Japanese women (1517 normal cytology …

The prevalence of COVID-19 vaccination and vaccine hesitancy in pregnant women: an internet-based cross-sectional study in Japan

Y Hosokawa, S Okawa, A Hori, N Morisaki… - Journal of …, 2022 - jstage.jst.go.jp
Background: Reluctance of people to receive recommended vaccines is a growing concern,
as distribution of vaccines is considered critical to ending the COVID-19 pandemic. There is …

[HTML][HTML] The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer

H Tokunaga, M Mikami, S Nagase… - Journal of …, 2021 - ncbi.nlm.nih.gov
The fifth edition of the Japan Society of Gynecologic Oncology guidelines for the treatment of
ovarian cancer, fallopian tube cancer, and primary peritoneal cancer was published in 2020 …